Revenue (Quarterly) Chart

View Revenue (Quarterly) for KSRYY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Quarterly) Chart
Start Trial

Historical Revenue (Quarterly) Data

View and export this data back to 2004. Start Trial.
Date Value
June 30, 2026 543.76M
March 31, 2026 498.83M
December 31, 2025 582.09M
September 30, 2025 542.55M
June 30, 2025 563.93M
March 31, 2025 518.34M
December 31, 2024 551.47M
September 30, 2024 533.33M
June 30, 2024 523.33M
March 31, 2024 522.53M
December 31, 2023 550.68M
September 30, 2023 516.50M
June 30, 2023 553.59M
March 31, 2023 514.80M
December 31, 2022 624.03M
September 30, 2022 508.08M
June 30, 2022 551.39M
March 31, 2022 507.37M
December 31, 2021 897.35M
September 30, 2021 582.85M
June 30, 2021 537.21M
March 31, 2021 706.82M
March 31, 2020 722.08M
December 31, 2019 719.91M
September 30, 2019 829.64M
Date Value
June 30, 2019 743.44M
March 31, 2019 772.71M
December 31, 2018 770.46M
September 30, 2018 722.35M
June 30, 2018 737.19M
March 31, 2018 737.16M
December 31, 2017 699.36M
September 30, 2017 666.23M
June 30, 2017 636.05M
March 31, 2017 655.41M
December 31, 2016 607.66M
September 30, 2016 619.10M
June 30, 2016 578.41M
March 31, 2016 563.82M
December 31, 2015 519.53M
September 30, 2015 482.28M
June 30, 2015 465.22M
March 31, 2015 491.02M
December 31, 2014 483.78M
September 30, 2014 477.30M
June 30, 2014 434.05M
March 31, 2014 513.41M
December 31, 2013 480.62M
September 30, 2013 473.42M
June 30, 2013 427.61M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Range, Past 5 Years

View Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Quarterly) Benchmarks

View Revenue (Quarterly) Benchmarks
Start Trial
Kao Corp. 2.879B
euglena Co., Ltd. 83.52M
Milbon Co., Ltd. 90.76M
Rohto Pharmaceutical Co., Ltd. 574.97M
Mandom Corp. 116.45M